NCT06058572View on ClinicalTrials.gov

Effect of Rifaximin on Gut Bacterial Flora Post Stem Cell Transplant in Patients With Acute Leukemia

PHASE2RecruitingINTERVENTIONAL
Enrollment

166

Participants

Timeline

Start Date

August 2, 2024

Primary Completion Date

August 2, 2027

Study Completion Date

August 2, 2027

Conditions
Acute Leukemia
Interventions
DRUG

Rifaximin 200Mg Tab

Drug rifaximin 200 mg tablet form orally twice daily (with or without food) from day-8 of transplant to day + 60 of transplant

PROCEDURE

allogenic hematopoietic stem cell transplantation

Control arm will undergo allogenic hematopoietic stem cell transplantation as standard of care

Trial Locations (1)

410210

RECRUITING

Actrec Tmc, Navi Mumbai

All Listed Sponsors
lead

Tata Memorial Centre

OTHER